EuBiologics secures FDA registration for EcML vaccine adjuvant

EuBiologics said Friday it has completed registration of its proprietary vaccine adjuvant EcML with the US Food and Drug Administration's Drug Master File system, obtaining an official filing number that is expected to facilitate future vaccine development and licensing partnerships.

The registration contains key chemistry, manufacturing and controls, or CMC, data, including information on EcML's raw materials, manufacturing process and quality specifications.

EuBiologics said the filing allows ...